Integrating bioethics into clinical and translational science research: a roadmap.
Recent initiatives to improve human health emphasize the need to effectively and appropriately translate new knowledge gleaned from basic biomedical and behavioral research to clinical and community application. To maximize the beneficial impact of scientific advances in clinical practice and community health, and to guard against potential deleterious medical and societal consequences of such advances, incorporation of bioethics at each stage of clinical and translational science research is essential. At the earliest stage, bioethics input is critical to address issues such as whether to limit certain areas of scientific inquiry. Subsequently, bioethics input is important to assure not only that human subjects trials are conducted and reported responsibly, but also that results are incorporated into clinical and community practices in a way that promotes and protects bioethical principles. At the final stage of clinical and translational science research, bioethics helps to identify the need and approach for refining clinical practices when safety or other concerns arise. The framework we present depicts how bioethics interfaces with each stage of clinical and translational science research, and suggests an important research agenda for systematically and comprehensively assuring bioethics input into clinical and translational science initiatives.
Shapiro
Robyn S
RS
Center for the Study of Bioethics, Department of Population Health, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, Wisconsin 53226, USA. rshapiro@mcw.edu
Layde
Peter M
PM
D001675:Bioethics / Q000639:trends*; D015510:Clinical Medicine; D002986:Clinical Trials as Topic; D003001:Cloning, Molecular; D019976:Cloning, Organism / Q000941:ethics; D032984:Ethics, Research; D005820:Genetic Testing; D006454:Hemoglobins / Q000627:therapeutic use; D006801:Humans; D015474:Isotretinoin / Q000627:therapeutic use; D057170:Translational Research, Biomedical / Q000941:ethics* / Q000639:trends*
D006454:Hemoglobins; C509893:PolyHeme; D015474:Isotretinoin